Dia Medica Therapeutics Inc. announced it raised $201,000 in an initial filing from an offering of $344,000

Apr 17, 2018•over 7 years ago

Amount Raised

$201,000

MinneapolisBiotechnology

Company Information

Company

DiaMedica Therapeutics

Location

301 CARLSON PARKWAY

Minneapolis, Minnesota, United States

About

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are available, with the focus on acute ischemic stroke and preeclampsia.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Dia Medica Therapeutics Inc. announced it raised $201,000 in an initial filing from an offering of $344,000

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information